beta-Lactamases: targets for drug design.
Coulton
S
S
Department of Medicinal Chemistry, SmithKline Beecham Pharmaceuticals, Brockham Park, Betchworth, Surrey, U.K.
François
I
I
D015195:Drug Design; D006801:Humans; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000627:therapeutic use
D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases